A new Merck & Co. study reveals that risk for heart attacks and strokes continues even when its use is discontinued. This risk continues for a year after use. In spite of the new study, Merck says it won't change its litigation strategy. Oh well, why be confused with the facts.
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/292 .